CD47

The CD-47 targeting therapeutics market is projected to grow at a CAGR of 42.9%, – Roots Analysis

Medical / /

Upon realizing the potential of this novel target, industry stakeholders have initiated several R&D efforts focused on exploiting the use of CD47 as an effective biomarker for the diagnosis and treatment purposes.   Roots Analysis has announced the addition of “CD-47 Targeting Therapeutics Market, 2021-2035” report to its list of offerings.   In recent years, […]

The CD-47 targeting therapeutics market is projected to grow at a CAGR of 42.9%, – Roots Analysis Read More »

The CD-47 targeting therapeutics market is estimated to be worth USD 7.1 billion in 2035- Roots Analysis

Health & Fitness / /

Upon realizing the potential of this novel target, industry stakeholders have initiated several R&D efforts focused on exploiting the use of CD-47 as an effective biomarker for the diagnosis and treatment purposes   Roots Analysis is pleased to announce the publication of its recent study, titled, “CD-47 Targeting Therapeutics Market, 2021-2035.”   The report features

The CD-47 targeting therapeutics market is estimated to be worth USD 7.1 billion in 2035- Roots Analysis Read More »